30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Dietz Thomas John

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 70% 68% 82%
Transactions
6 83% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -90%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Dietz Thomas John's trades of Eiger BioPharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-25 2023-01-23
B Purchase
15,806 -23.4%
460.45
US$2,000,810 		15,806 -23.4% 460.45 US$2,000,810
2022-12-27 2022-12-22
S Sale
91,318 -1.9%
206.84
US$937,769 		91,318 -1.9% 206.84 US$937,769
2020-03-17 2020-03-16
B Purchase
86,069 +40.1%
403.73
US$4,819,319 		86,069 +40.1% 403.73 US$4,819,319
2020-01-13 2020-01-10
B Purchase
4,000 +20.0%
13.94
US$55,760 		4,000 +20.0% 13.94 US$55,760
2019-04-23 2019-04-23
B Purchase
5,000 +33.3%
11.10
US$55,495 		5,000 +33.3% 11.10 US$55,495
2019-04-22 2019-04-22
B Purchase
5,000 +50.0%
11.05
US$55,250 		5,000 +50.0% 11.05 US$55,250
2019-02-20 2019-02-15
PlS Planned sale
3,000 -40.0%
7.14
US$21,420 		3,000 -40.0% 7.14 US$21,420